NARA MEDICAL UNIVERSITY
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- Private
- Established
- 1945-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.naramed-u.ac.jp
Clinical Trials
6
Active:0
Completed:2
Trial Phases
2 Phases
Phase 4:3
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 4
3 (75.0%)Not Applicable
1 (25.0%)Basic Study of Combination Therapy Based on APCC-induced FVllI Activation in Hemophilia A Patients With Inhibitors
- Conditions
- Hemophilia A With Inhibitor
- First Posted Date
- 2015-09-18
- Last Posted Date
- 2015-09-18
- Lead Sponsor
- Nara Medical University
- Target Recruit Count
- 10
- Registration Number
- NCT02554526
- Locations
- 🇯🇵
Department of Pediatrics, Kashihara, Nara, Japan
New Angiotensin II Receptor Blocker Azilsartan Study for Stronger Blood Pressure Lowering
- First Posted Date
- 2012-06-01
- Last Posted Date
- 2013-10-30
- Lead Sponsor
- Nara Medical University
- Target Recruit Count
- 70
- Registration Number
- NCT01609959
- Locations
- 🇯🇵
First Department of Nara Medical University, Kashihara, Nara, Japan
The Effects of Carperitide on Short and Long-term Prognosis in Patients With Both Cardiac and Renal Failure
Phase 4
Terminated
- Conditions
- Heart FailureRenal Failure
- Interventions
- Drug: Standard heart failure therapy
- First Posted Date
- 2008-02-13
- Last Posted Date
- 2011-07-22
- Lead Sponsor
- Nara Medical University
- Target Recruit Count
- 200
- Registration Number
- NCT00613964
- Locations
- 🇯🇵
First Department of Internal Medicine, Nara Medical University, Nara, Japan
Hemofiltration for Contrast-Induced Nephropathy
Not Applicable
- Conditions
- Chronic Kidney DiseaseCardiac Catheterization
- First Posted Date
- 2005-09-12
- Last Posted Date
- 2005-09-12
- Lead Sponsor
- Nara Medical University
- Target Recruit Count
- 100
- Registration Number
- NCT00158080
- Locations
- 🇯🇵
First Dept of InternalMedicine, Nara Medical University, Kashihara, Nara, Japan
Angiotensin II Receptor Blockers (ARB) and ACE Inhibitors (ACEI) on Silent Brain Infarction and Cognitive Decline
Phase 4
Completed
- Conditions
- Brain InfarctionHypertension
- Interventions
- Drug: Angiotensin-converting Enzyme Inhibitors
- First Posted Date
- 2005-08-04
- Last Posted Date
- 2013-10-30
- Lead Sponsor
- Nara Medical University
- Target Recruit Count
- 395
- Registration Number
- NCT00126516
- Locations
- 🇯🇵
First Department of Internal Medicine, Nara Medical University, Kashihara, Nara, Japan
News
Japan Launches World's First Clinical Trials for Artificial Blood in 2025
Japan will begin the world's first clinical trials for artificial blood by March 2025, led by Nara Medical University, marking a potential breakthrough in emergency medicine.